Legal Representation
Attorney
Yoon S. Ham
USPTO Deadlines 2 active
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
MAINTENANCE
Section 8 (6-Year) Declaration Due (Based on registration date 2020-08-11) |
R.PRA | Aug 11, 2026 | 400 days | Critical | No |
|
MAINTENANCE
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2020-08-11) |
R.PRA | Aug 11, 2030 | 1861 days | Critical | No |
Next deadline: Section 8 (6-Year) Declaration Due (Based on registration date 2020-08-11)
on August 11, 2026
(400 days)
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Dec 26, 2020 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Dec 3, 2020 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Dec 3, 2020 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Nov 11, 2020 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Aug 11, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jun 12, 2020 | CHPB | I | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Jun 12, 2020 | GPNX | P | NOTIFICATION PROCESSED BY IB |
| Jun 11, 2020 | APET | A | ASSIGNED TO PETITION STAFF |
| May 26, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 26, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| May 11, 2020 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| May 6, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| May 6, 2020 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| May 6, 2020 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Apr 21, 2020 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Apr 13, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Apr 13, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Apr 13, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Apr 13, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Apr 13, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Apr 2, 2020 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Mar 20, 2020 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Mar 10, 2020 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Mar 4, 2020 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Mar 4, 2020 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Feb 26, 2020 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Feb 19, 2020 | ISMR | Z | WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST |
| Feb 19, 2020 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Feb 19, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Feb 19, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Feb 19, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Feb 19, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Feb 19, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jan 14, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 14, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 10, 2020 | GPNX | P | NOTIFICATION PROCESSED BY IB |
| Dec 25, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Dec 25, 2019 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Dec 25, 2019 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Dec 10, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 6, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Dec 6, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Dec 2, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jul 30, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jul 30, 2019 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Jul 30, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jul 23, 2019 | LOPT | I | LETTER OF PROTEST EVIDENCE FORWARDED |
| May 30, 2019 | CNSL | R | SUSPENSION LETTER WRITTEN |
| May 30, 2019 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
| May 30, 2019 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Detailed Classifications
Class 005
Medicines for humans used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Medicines for humans used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Hunter Syndrome, Hemophilia, Hemophilia A, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, virus infection, influenza, bacterial infection and chronic pain; Medicines for humans, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; medicated plasters; vaccines; biological preparations for medical or veterinary purposes, namely, biological preparations used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Hunter Syndrome, Hemophilia, Hemophilia A, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, virus infection, influenza, bacterial infection and chronic pain; biological preparations for medical or veterinary purposes, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Medical apparatus and instruments for use in performing biopsies; medical testing apparatus for medical purposes, namely, medical apparatus for testing DNA and RNA samples; medical diagnostic apparatus and instruments for immunodiagnosis and molecular diagnosis; electromedical diagnostic instruments for immunodiagnosis and molecular diagnosis; apparatus for use in medical analysis, namely, medical apparatus for blood test; medical health signal measuring instruments for monitoring vital signs; wireless bio-signal measuring instruments for medical purposes, namely, biofeedback sensors; precision sensors for medical use, namely, heart rhythm sensors, respiratory sensors and biofeedback sensors; laser machining tools for medical use, namely, lasers for surgical and medical use; genetic testing apparatus, namely, apparatus for DNA and RNA testing for medical purposes
First Use Anywhere:
0
First Use in Commerce:
0
Class 035
Retail store services featuring pharmaceutical preparations for the treatment of cells; retail store services featuring medical instruments; retail store services featuring medical apparatus; retail store services featuring biological preparations for medical purposes; retail store services featuring medical genetic analyzer; retail and wholesale store services featuring pharmaceutical preparations; import-export agency services; retail store services featuring electromedical diagnostic instruments; wholesale store services featuring pharmaceutical preparations for the treatment of cells; wholesale store services featuring medical instruments; wholesale store services featuring medical apparatus; wholesale store services featuring biological preparations for medical purposes; wholesale store services featuring medical genetic analyzer; wholesale store services featuring electromedical diagnostic instruments; all the foregoing excluding services in the field of industrial, institutional, commercial and janitorial equipment and supplies
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development of vaccines and medicines; conducting clinical studies of medicines for medical research purposes; clinical research in the nature of performing biopsies for medical research; product research and development of medical products; conducting technical project studies, namely, engineering services in the nature of technical project planning and design engineering of medical products; testing, inspection or research of pharmaceuticals; scientific research relating to biology; scientific research in the field of genetic engineering; research and development of technology for biotechnology; scientific research in the fields of biomedicine; laboratory research in the field of biology; product development of cell therapy products; drug discovery services; research and development in the pharmaceutical and biotechnology fields; scientific research in the field of gene analysis; medical studies, namely, medical laboratory services; research and development of technology for medicinal chemical manufacturing; medical research services relating to clinical data
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical services, namely, the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow for medical preventive, diagnostic and treatment purposes; medical examination services; health clinic services, namely, medical clinics; analysis of human tissues for medical diagnosis purposes and treatment; medical consultancy for selecting appropriate medicines; human tissue bank services; medical services, namely, clinical pathology examination; cord blood bank services; health center services; medical and pharmaceutical consultancy; medical and health care services; pharmacy services, namely, dispensing of pharmaceuticals; consultancy and information services relating to the dispensing of pharmaceutical products; dispensing of pharmaceuticals; preparation and dispensing of medications; information services relating to utilization of medical products in connection with the provision of medical services; medical and health services relating to DNA, genetics and genetic testing; managed health care services
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of a stylized rounded cross with the top and right arms in red fading toward the middle to orange then to yellow, and the left and lower arms in green; to the right of the cross are the letters "GC" in deep blue.
Color Claim
The color(s) red, orange, yellow, green and deep blue is/are claimed as a feature of the mark.
Classification
International Classes
005
010
035
042
044